Drug Trial Radar · NCT01073228
Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease
Last checked: Nov 20, 2026Latest source record: Apr 25, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
409
Actual
Start
Apr 2010
Primary completion
Nov 2011
Study completion Feb 2012
Sponsor
- Lead sponsor
- FORUM Pharmaceuticals IncIndustry
- Sponsor type
- Industry
- Collaborators
- INC Research Limited
- First posted
- Feb 23, 2010
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 50 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is being conducted to determine the safety and effect on cognitive function of the investigational medication, EVP-6124, in individuals with mild to moderate probable Alzheimer's disease.
Conditions
- Alzheimer's Disease
- Central Nervous System Diseases
- Cognition
Interventions
EVP-6124Drug
PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Alzheimer's Disease Assessment Scale-Cognitive subscale-13 (ADAS-cog-13)Time frame: Day -7, Baseline, 4, 12, 18, 23 Weeks
Locations
54 sites in 5 countries. Site status is shown where the registry gives one.
HOPE Research Institute
Phoenix, Arizona
Catalina Research Institute
Chino, California
ATP Clinical Research
Costa Mesa, California
University of California, Irvine
Orange, California
Radiant Research
Santa Rosa, California
Research Center for Clinical Studies, Inc.
Norwalk, Connecticut
Chase Medical Research, LLC
Waterbury, Connecticut
Meridien Research
Brooksville, Florida
Brain Matters Research
Delray Beach, Florida
MD Clinical
Hallandale, Florida
Galiz Research
Miami Springs, Florida
Renstar Medical Research
Ocala, Florida
Compass Research, LLC
Orlando, Florida
Princeton Medical Institute
Princeton, New Jersey
Memory Enhancement Center of NJ
Toms River, New Jersey
Brooklyn Medical Institute
Brooklyn, New York
Social Psychiatry Research Institute
Brooklyn, New York
Advanced Bio Behavioral Sciences Inc.
Elmsford, New York
University of Rochester Medical Center at MCH
Rochester, New York
Columbus Research and Wellness Institute
Columbus, Ohio
Summit Research Network
Portland, Oregon
FutureSearch Trials of Dallas, L.P.
Dallas, Texas
Grayline Clinical Drug Trials
Wichita Falls, Texas
The Memory Clinic
Bennington, Vermont
The Center for Excellence in Aging and Geriatric Health
Williamsburg, Virginia
Clinical Site 1
Bucharest, Romania
Clinical Site 2
Bucharest, Romania
Clinical Site 3
Bucharest, Romania
Clinical Site 4
Bucharest, Romania
Clinical Site 5
Bucharest, Romania
Site not named
Iași, Romania
Site not named
Oradea, Romania
Site not named
Târgu Mureş, Romania
Site not named
Kazan', Russia
Clinical Site 1
Moscow, Russia
Clinical Site 2
Moscow, Russia
Clinical Site 1
Saint Petersburg, Russia
Clinical Site 2
Saint Petersburg, Russia
Clinical Site 3
Saint Petersburg, Russia
Clinical Site 4
Saint Petersburg, Russia
Showing 40 of 54 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.